[1] 管子姝,郜玉峰,代倩,等. 中性粒细胞与淋巴细胞比值对ALT小于2倍正常值上限的慢性乙型肝炎病毒感染患者肝脏炎症的诊断价值. 安徽医科大学学报,2017,52:550-553.
[2] Hou J,Wang G,Wang F,et al. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). J Hepatol,2017,5:297-318.
[3] 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊疗指南. 中华肝脏病杂志,2006,14:643-646.
[4] Moreau R,Jalan R,Gines P,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology,2013,144:1426-1437.
[5] Fischer J,Silva TE,Eduardo SESP,et al. From stable disease to acute-on-chronic liver failure: Circulating cytokines are related to prognosis in different stages of cirrhosis. Cytokine,2017,91:162-169.
[6] 李元元,耿华,于双杰,等.中性粒细胞与淋巴细胞比值与乙型肝炎相关性慢加急性肝衰竭疾病进展的临床研究.胃肠病学和肝病学杂志,2016,25:411-414.
[7] 罗光成,黄云丽,闫惠平,等. HBV相关慢加急性肝衰竭患者血清细胞因子水平与疾病预后的关系研究. 检验医学,2014,29:26-30.
[8] Gao F,Sun L,Ye X,et al. Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure. Eur J Gastroen Hepat,2017,29:669-678.
[9] 郭鸿雁.中性粒细胞淋巴细胞比值在预测乙肝肝衰竭中的诊断价值分析.胃肠病学和肝病学杂志,2018,27:93-98. |
